In vitro studies of the role of CD3+ and CD56+ cells in fetal liver cell alloreactivity

Transplantation

Volumn 76, Issue 1, 2003, Pages 204-209

  Lindton, Bim ^a   Markling, Lola ^a   Ringdén, Olle ^a   Westgren, Daagnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; HLA ANTIGEN CLASS 2;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; FETUS; FETUS LIVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; LYMPHOCYTE DEPLETION; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037623950     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000067527.48418.DB     Document Type: Article

References (33)

1. Pearce RD, Kiehm D, Armstrong DT, et al. Induction of hemopoietic chimerism in the caprine fetus by intraperitoneal injection of fetal cells. Experientia 1989; 45(3): 307-308.
2. Zanjani ED, Flake AW, Rice H, et al. Long-term repopulation ability of xenogenic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 1994; 93: 1051-1055.
3. Shields LE, Bryant EM, Easterling TR, et al. Fetal liver cell transplantation for creation of lymphohematopoietic chimerism in fetal baboons. Am J Obstet Gynecol 1995; 173: 1157-1160.
4. Touraine JL, Raudrant D, Royo C, et al. In utero transplantation of stem cells in bare lymphocyte syndrome. Lancet 1989; i: 1382.
5. Flake AW, Puck JM, Almeida-Porada G, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996; 335: 1806-1810.
6. Wengler GS, Lanfranchi A, Frusca T, et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996; 348: 1484-1487.
7. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biological barriers. Blood 1999; 94(7): 2179-2191.
8. Westgren M, Ringdén O, Eik-Nes S, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996; 61: 1176-1179.
9. Lindton B, Markling L, Ringdén O, et al. Mixed lymphocyte culture of human fetal liver cells. Fetal Diagn Ther 2000; 15: 71-78.
10. Stites DP, Carr MC, Fudenberg HH. Ontogeny of cellular immunity in the human fetus: Development of response to phytohemagglutinin and to allogenic cells. Cell Immunol 1974; 11: 257-271.
11. Toivanen P, Uksila J, Leino A, et al. Development of mitogen responding T cells and natural killer cells in the human fetus. Immunol Rev 1981; 57: 89-105.
12. Ayoub J, Kasakura S. In vitro response to foetal lymphocytes to PHA, and a factor plasma which suppresses the PHA response of adult lymphocytes. Clin Exp Immunol 1971; 8(3): 427-434.
13. Seaman WE. Natural killer cells and natural killer T cells. Arthritis Rheum 2000; 43(6): 1204-1217.
14. Persson PH, Weldner BM. Normal range growth curves for fetal biparietal diameter, occipito frontal diameter, mean abdominal diameters and femur length. Acta Obstet Gynecol Scand 1986; 65: 759-761.
15. 1 methyl ester). Prostaglandins 1992; 44: 65-74.
16. England MA. A color atlas of life before birth: normal fetal development. London, Wolfe Medical Publications 1988.
17. Bach FH, Hirschbom K. Science 1964; 143: 813.
18. Ringden O, Möller E, Lundgren G, et al. Role of MLC compatibility in intrafamilial kidney transplantation. Transplantation 1976; 22(1): 9-17.
19. Ek S, Ringdén O, Markling L, et al. Immunological capacity of human fetal liver cells. Bone Marrow Transplant 1994; 14: 9-14.
20. Renda MC, Fecarotta E, Dieli F, et al. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25: 135-141.
21. Carson W, Caligiuri M. Natural killer cell subsets and development. Methods 1996; 9(2): 327-343.
22. Carlyle JR, Michie AM, Furlonger C, et al. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997; 186(2): 173-182.
23. Phillips JH, Hori T, Nagler A, et al. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med 1992; 175(4): 1055-1066.
24. Thilaganathan B, Abbas A, Nicolaides KH. Fetal blood natural killer cells in human pregnancy. Fetal Diagn Ther 1993; 8: 149-153.
25. Uksila J, Lassila O, Hirvonen T, et al. Development of natural killer cell function in the human fetus. J Immunol 1983; 130(1): 153-156.
26. Chargui J, Moya MJ, Sanhadji K, et al. Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells. Thymus 1997; 24(4): 233-246.
27. + T cells in thymus, cord and adult blood. Immunology 2002; 106: 190-199.
28. Lo Y, Lo ESF, Watson N. Two-way cell traffic between mother and fetus: biological and clinical implications. Blood 1996; 88: 4390-4395.
29. Lo Y, Lau T, Chan L, et al. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma-DNA. Clin Chem 2000; 46: 1301-1309.
30. Scaradavon A, Carrier C, Mollen N, et al. Detection of maternal DNA in placental/umbilical cord blood by locus: specific amplification of the noninherited maternal HLA-gene. Blood 1996; 88: 1494-1500.
31. Sottini A, Quiros-Roldan E, Notarangelo L, et al. Engrafted maternal T cells in a severe combined immunodeficiency patient express T cell receptor variable beta segments characterized by a restricted V-D-J junctional diversity. Blood 1995; 85: 2105-2113.
32. Muller SM, Ege M, Pottharst A, et al. Transplacentally acquired maternal T-lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001; 98(6): 1847-1851.
33. + natural killer cells in the endometrium of women suffering spontaneous early pregnancy loss. Hum Reprod 1996; 11: 1569.